Aedes Research Virtual Conference (Aedes-2025)
November 3-4, 2025 | Online | Eastern Time (US & Canada)
Aedes-transmitted diseases—including dengue, chikungunya, Zika, and yellow fever—are increasingly threatening global health, with dengue currently the most widespread. In 2024, over 14 million symptomatic dengue cases and more than 10,000 deaths were reported, with Latin America, Asia, and parts of Africa hardest hit. Chikungunya, though less deadly, is resurging rapidly across Africa, Southeast Asia, and southern Europe, causing debilitating joint pain and long-term health issues. Zika virus, known for causing birth defects, remains present in over 89 countries, with recent spikes in India. Yellow fever, although vaccine-preventable, continues to cause severe outbreaks in parts of Africa and South America, with WHO classifying it as a high-priority re-emerging threat due to inconsistent immunization coverage and growing mosquito ranges.
Climate change, urbanization, global travel, and inadequate vector control are accelerating the global spread of Aedes aegypti and Aedes albopictus mosquitoes. In response, the World Health Organization launched the Global Arbovirus Initiative and a strategic response plan in 2024 to strengthen global readiness against Aedes-borne diseases. This includes enhanced surveillance, vector control, and standardized clinical management for dengue, chikungunya, Zika, and yellow fever. New WHO clinical guidelines in 2025 emphasize early diagnosis, fluid management for dengue, and continued yellow fever vaccination campaigns to prevent major epidemics. With up to 5.6 billion people at risk and Aedes mosquitoes rapidly expanding into new geographic regions—including urban centers, temperate zones, southern Europe, and higher altitudes—the urgency for early detection, treatment options, vaccine development, and effective vector control has never been greater. This growing threat underscores the critical need for sustained public health investment and strong international cooperation.
Aedes-2025
We are pleased to invite you to the Aedes Research Virtual Conference (Aedes-2025), organized by Impact Research Communications, to be held online on November 3-4, 2025. This virtual gathering offers a vital platform for academics (e.g., entomologists, virologists), industry researchers (e.g., vaccine developers, vector control innovators) and public health professionals to share knowledge, advancements, and strategies in understanding and combating Aedes-transmitted diseases.
Why Attend?
• Access the Latest Research: Gain insights from distinguished experts presenting
cutting-edge research on Aedes-transmitted diseases.
• Flexible Learning: Access recorded sessions at
your
convenience—perfect for global participants across time zones.
• Global Engagement: Network with international researchers, clinicians, and
healthcare
professionals through interactive virtual sessions.
• Affordable & Accessible: Enabling global participation, particularly for
researchers in
resource-limited regions heavily affected by Aedes-borne diseases—such as Southeast Asia and Latin
America—this
high-impact virtual event eliminates travel and accommodation barriers, allowing attendees to engage fully
from
anywhere in the world.
• Official Recognition: Receive a Certificate of
Participation, enhancing your academic and professional credentials.
Discover our esteemed lineup of speakers and take part in a dynamic two-day program that delves into the latest trends, pressing challenges, and groundbreaking advancements in the study of Aedes-transmitted viruses such as dengue, Zika, chikungunya, and yellow fever.
We look forward to welcoming youvirtually on November 3-4, 2025!
Email: akakarla@ircconferences.net

